Does BOTULINUM TOXIN TYPE A Cause Dermatitis? 5 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Dermatitis have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 0.1% of all adverse event reports for BOTULINUM TOXIN TYPE A.
5
Reports of Dermatitis with BOTULINUM TOXIN TYPE A
0.1%
of all BOTULINUM TOXIN TYPE A reports
0
Deaths
4
Hospitalizations
How Dangerous Is Dermatitis From BOTULINUM TOXIN TYPE A?
Of the 5 reports, 4 (80.0%) required hospitalization.
Is Dermatitis Listed in the Official Label?
Yes, Dermatitis is listed as a known adverse reaction in the official FDA drug label for BOTULINUM TOXIN TYPE A.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Dermatitis?
DUPILUMAB (3,823)
ADAPALENE (2,088)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (1,615)
ADALIMUMAB (530)
METHOTREXATE (452)
ETANERCEPT (317)
SECUKINUMAB (294)
INFLIXIMAB (268)
NIVOLUMAB (251)
DENOSUMAB (246)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Dermatitis Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE